These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21050062)

  • 41. Streamlining the future: exploring data submission solutions for the small provider.
    Delva O
    Nephrol News Issues; 2011 Apr; 25(4):26-7. PubMed ID: 21542510
    [No Abstract]   [Full Text] [Related]  

  • 42. Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients.
    Schumock GT; Andress DL; Marx SE; Sterz R; Joyce AT; Kalantar-Zadeh K
    Nephron Clin Pract; 2009; 113(1):c54-61. PubMed ID: 19590235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The marginal cost of satellite versus in-center hemodialysis.
    Soroka SD; Kiberd BA; Jacobs P
    Hemodial Int; 2005 Apr; 9(2):196-201. PubMed ID: 16191069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of delayed nephrologist referral in patients with chronic kidney disease.
    Winkelmayer WC; Glynn RJ; Levin R; Owen WF; Avorn J
    Am J Kidney Dis; 2001 Dec; 38(6):1178-84. PubMed ID: 11728948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
    Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
    Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacy program with DM component targets CKD.
    Dis Manag Advis; 2008 Jan; 14(1):8-10, 1. PubMed ID: 18286988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancer.
    Lage MJ; Borker R; Barber B; Gao S
    J Med Econ; 2010; 13(4):691-7. PubMed ID: 21070099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lessons learned in an urban CKD clinic.
    Crawford PW
    Nephrol News Issues; 2005 Jan; 19(2):43, 47-9. PubMed ID: 15717574
    [No Abstract]   [Full Text] [Related]  

  • 49. Improving workflow in the dialysis clinic (part 1).
    Hamilton G; Sessoms M
    Nephrol News Issues; 2011 Oct; 25(11):32, 34, 36 passim. PubMed ID: 22128503
    [No Abstract]   [Full Text] [Related]  

  • 50. Antihypertensive medication adherence and subsequent healthcare utilization and costs.
    Pittman DG; Tao Z; Chen W; Stettin GD
    Am J Manag Care; 2010 Aug; 16(8):568-76. PubMed ID: 20712390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving workflow in the dialysis clinic: part 2.
    Sessoms M; Hamilton G
    Nephrol News Issues; 2011 Nov; 25(12):27-8, 30, 32-4 passim. PubMed ID: 22204166
    [No Abstract]   [Full Text] [Related]  

  • 53. Cognitive pharmacy services at a pediatric nephrology and hypertension clinic.
    So TY; Layton JB; Bozik K; Farrington E; Gipson PE; Gibson K; Primack W; Conley W; Gipson DS; Ferris M
    Ren Fail; 2011; 33(1):19-25. PubMed ID: 21219201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Geriatric assessment for the nephrologist.
    Wiggins J; Bitzer M
    Semin Dial; 2012; 25(6):623-7. PubMed ID: 23173890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.
    Van Biesen W; Lameire N; Peeters P; Vanholder R
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):133-48. PubMed ID: 17638074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. International study of health care organization and financing: development of renal replacement therapy in Germany.
    Kleophas W; Reichel H
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):185-200. PubMed ID: 17701342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Progress in clinical nephrology 2008: CKD, and AKI as well].
    Watanabe T
    Nihon Jinzo Gakkai Shi; 2009; 51(1):13-8. PubMed ID: 19238902
    [No Abstract]   [Full Text] [Related]  

  • 58. Competition under fixed prices: effects on patient selection and service strategies by hemodialysis providers.
    Farley DO
    Med Care Res Rev; 1996 Sep; 53(3):330-49. PubMed ID: 10159932
    [No Abstract]   [Full Text] [Related]  

  • 59. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.
    Manns BJ; Mendelssohn DC; Taub KJ
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):149-69. PubMed ID: 17641968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.
    Pontoriero G; Pozzoni P; Vecchio LD; Locatelli F
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):201-15. PubMed ID: 17641969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.